Compare Progeny Clinical vs. Unlearn

Explore our efficient screening tools designed to identify patients at a high risk for breast, colorectal, and other types of cancer. Progeny Clinical streamlines the management of family histories, risk assessments, and treatment options for your patients. You can gather family history information online and automatically create pedigrees prior to the clinic appointment. Modify existing pedigrees or create new ones at any time. Execute validated hereditary cancer risk assessment models with a single click, eliminating the need to re-enter data. Simplify the process by ordering genetic testing through Ambry Genetics. Monitor and analyze results from any laboratory without leaving the software environment. Enhance efficiency by generating letters, consultation notes, reports, and documents using custom templates that incorporate patient data fields. Utilize pre-configured or tailored data input screens to swiftly create custom queries and spreadsheet reports. Moreover, you can integrate a hyperlink within your electronic medical record to conveniently access the patient’s latest pedigree. This innovative approach not only saves time but also optimizes patient care and enhances workflow efficiency.

Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.